Synergen Inc

Basic Information

1885 33rd St
Boulder, CO, 80301

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. ANTIPLAQUE PROTEINS VIA GENETIC ENGINEERING

    Amount: $440,212.00

    SYNERGEN, INC.'S PROPOSED RESEARCH WILL DEVELOP, THROUGH RECOMBINANT DNA METHODS, NEW AGENTS TO CONTROL DENTAL PLAQUETHESE WILL CONSIST OF AN ENZYMATIC MOIETY OF THERAPEUTIC VALUE FUSED WIH AN ADHESIV ...

    SBIR Phase II 1989 Department of Health and Human Services
  2. KALLIKREIN INHIBITORS BY GENETIC ENGINEERING

    Amount: $50,000.00

    THE AIM OF THIS RESEARCH IS TO PRODUCE INHIBITORS OF HUMAN KALLIKREINS THAT BLOCK KALLIKREIN-MEDIATED CONVERSION OF KININOGENS INTO KININS. KININS ARE IMPLICATED IN THE SYMPTOMS OF ALLERGIC RHINITIS, ...

    SBIR Phase I 1989 Department of Health and Human Services
  3. NEW DRUG FOR PREVENTING POST-ISCHEMIC TISSUE INJURY

    Amount: $50,000.00

    NEUTROPHILS ARE A MAJOR CONTRIBUTOR TO THE CELLULAR DAMAGE THAT ACCOMPANIES REPERFUSION OF ISCHEMIC TISSUES. IT IS PLANNED TO CLONE AND PRODUCE THROUGH RECOMBINANT DNA METHODS A HUMAN PROTEIN THAT BLO ...

    SBIR Phase I 1989 Department of Health and Human Services
  4. VACCINE AGAINST HAEMOPHILUS INFLUENZAE TYPE B

    Amount: $49,766.00

    THIS RESEARCH WILL LEAD TO THE DEVELOPMENT OF A VACCINE THAT CAN BE USED TO PROTECT YOUNG CHILDREN AGAINST INFECTIONS CAUSED BY HAEMOPHILUS INFLUENZAE TYPE B (HIB). THE VACCINE WILL BE BASED ON THE PI ...

    SBIR Phase I 1989 Department of Health and Human Services
  5. DEVELOPMENT OF AMIDASES FOR USE IN BETA-LACTAM MODIFICATION

    Amount: $50,000.00

    SEVERAL CLINICALLY IMPORTANT BETA-LACTAM ANTIBIOTICS ARE PRODUCED THROUGH CONDENSATION OF D-(-)-ALPHA-AMINOPHENYLACETIC ACID WITH PENAM AND CEPHEM NUCLEI IN MULTI-STEP CHEMICAL PROCESSES. AN EFFICIENT ...

    SBIR Phase I 1988 Department of Health and Human Services
  6. THERAPEUTIC CLEARANCE OF COMPLEMENT FRAGMENT C5A

    Amount: $50,000.00

    THE OVERALL GOAL OF THE PROPOSED RESEARCH IS TO PROVIDE A SPECIFIC, PRACTICAL MEANS FOR INACTIVATING C5A IN PATIENTS AT RISK OF ADULT RESPIRATORY DISTRESS SYNDROME (ARDS). C5A IS A KEY CONTRIBUTORY, P ...

    SBIR Phase I 1988 Department of Health and Human Services
  7. A HUMAN IL-1 INHIBITOR FOR THE TREATMENT OF SEPTIC SHOCK

    Amount: $49,326.00

    WE PROPOSE TO PURIFY AN IL-1 INHIBITOR FROM THE SUPERNATANT OF MONOCYTES CULTURED ON PLATES COATED WITH IGG. THIS INHIBITORY ACTIVITY HAS BEEN SHOWN TO BE ABOUT 22 KILODALTONS IN MOLECULAR WEIGHT AND ...

    SBIR Phase I 1988 NavyDepartment of DefenseDepartment of Defense
  8. ANTIPLAQUE PROTEINS VIA GENETIC ENGINEERING

    Amount: $50,000.00

    N/A

    SBIR Phase I 1987 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government